Can individuals with penicillin allergy receive the COVID-19 vaccine?
Penicillin is an anti-inflammatory drug used to treat diseases such as pneumonia and meningitis. It generally exhibits stronger activity against Gram-negative bacteria than against Gram-positive bacteria, and demonstrates greater efficacy against *Salmonella typhi*, *Haemophilus influenzae*, and *Bordetella pertussis* compared with other antibiotics. However, it is essential to perform an intradermal skin test prior to penicillin administration to prevent allergic reactions. So, can individuals with penicillin allergy receive the COVID-19 vaccine? Below, we address this question.

Can individuals with penicillin allergy receive the COVID-19 vaccine?
In general, individuals with penicillin allergy may safely receive the COVID-19 vaccine. However, those with a history of severe allergic reactions should proceed with caution and consult a physician before vaccination. Penicillin is a broad-spectrum antibiotic that exerts bactericidal effects, whereas the COVID-19 vaccine is an immunobiological agent containing inactivated or attenuated virus particles designed to stimulate protective immunity. Therefore, penicillin allergy does not interfere with the safety or efficacy of the COVID-19 vaccine. After vaccination, proper post-injection care is essential: avoid wetting the injection site to prevent infection. Additionally, prevention of SARS-CoV-2 infection requires individual responsibility—minimize unnecessary outings, avoid crowded places, and consistently wear a face mask when outdoors.

Additional Information: Adverse Reactions to Penicillin
1. Respiratory Distress
Some patients exhibit extreme hypersensitivity to penicillin—even minute amounts may trigger anaphylactic shock. Intravenous administration may provoke seizure-like episodes; therefore, clinical guidelines mandate an intradermal skin test prior to penicillin injection. Potential respiratory manifestations include chest tightness, shortness of breath, laryngeal obstruction, dyspnea, and asphyxia, resulting from bronchospasm, mucosal edema, and pulmonary edema.
2. Cutaneous Allergic Reactions
Cutaneous manifestations may include rash, pruritus, and fever—either concurrently or independently—with rash being the most common. Rashes vary widely in morphology; severe cases may involve toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or exfoliative dermatitis—potentially life-threatening conditions. Ampicillin-induced rashes are particularly frequent and may present as pruritus, urticaria, or other maculopapular eruptions; allergic purpura may also occur.

3. Neurological and Psychiatric Disturbances
Neurological symptoms may include hyperreflexia, sensory disturbances, seizures, and somnolence. These typically resolve upon discontinuation or dose reduction of penicillin. Such manifestations likely stem from cerebral hypoxia leading to central nervous system dysfunction—including loss of consciousness, coma, convulsions, and urinary/fecal incontinence. Rarely, long-term sequelae such as aphasia, hemiplegia, or Parkinsonism may develop.
The above outlines whether individuals with penicillin allergy may receive the COVID-19 vaccine. We hope this information proves helpful.